InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-15.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by MARIE-PAULE RICHARD, Directrice médicale. Insider active across 1 company, notably INVENTIVA. Cumulatively, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. History available since 14 December 2020. The latest transaction was disclosed on 8 December 2021 (Acquisition gratuite d'actions). Regulator: AMF. The full history is openly available.
Declarations2 total
15,000 shares0ActionHors plateforme de négociation2021DD736965
Ideal exit: 4 Sept 2022 (T+270)
30,000 shares0ActionHors plateforme de négociation2021DD736964
Ideal exit: 10 Sept 2021 (T+270)
2 of 2 declarations
About MARIE-PAULE RICHARD
Marie-Paule Richard is the Chief Medical Officer at INVENTIVA, a biopharmaceutical company. She is responsible for medical strategy and overseeing clinical trials, contributing to innovation and the development of new treatments.
